Treatment of 2-phenoxypropionic acid with polyphosphoric acid gave substituted benzofuran-3-ones (2a-h), which were converted into 2,3,4-trihydrodibenzofuran-3-ones (4a-h) via the compounds 3a-h. Clemmensen reduction of the compounds 4a-h gave the 2,3,4-trihydrodibenzofuranes(5a-h).
(2-ARYLOXYACETYLAMINO) PHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS
申请人:DEFOSSA Elisabeth
公开号:US20120004167A1
公开(公告)日:2012-01-05
The invention relates to substituted (2-aryloxyacetylamino)phenylpropionic acid derivatives, and to the physiologically acceptable salts thereof.
The invention relates to compounds of the formula I
in which R1, R2, R3, R4, R5, R6, R7, R8, R9 and A are each defined as specified, and the physiologically compatible salts thereof. The compounds are suitable, for example, for treatment of diabetes.
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
申请人:Defossa Elisabeth
公开号:US08648038B2
公开(公告)日:2014-02-11
The invention relates to substituted (2-aryloxyacetylamino)phenylpropionic acid derivatives, and to the physiologically acceptable salts thereof.
The invention relates to compounds of the formula I
in which R1, R2, R3, R4, R5, R6, R7, R8, R9 and A are each defined as specified, and the physiologically compatible salts thereof. The compounds are suitable, for example, for treatment of diabetes.
The present invention relates to new 1-methylpyrazole modulators of substance P release, calcitonin gene-related peptide activity, adrenergic receptor activity, and/or 5-HT receptor activity, pharmaceutical compositions thereof, and methods of use thereof.